-
Multidimensional Impacts of Elexacaftor/Tezacaftor/Ivacaftor: Comparisons of Physical and Mental Health Providers' Observations in Cystic Fibrosis in Europe and the United States
Graziano, S., Landau, E. C., Mitmansgrubert, H., Verkleij, M., Georgiopoulos, A. M., Borawska-Kowalczyk, U., Smith, B. A., Bathgate, C. J. & Quittner, A. L., Nov 2025, In: Pediatric Pulmonology. 60, 11, e71367.Research output: Contribution to journal › Article › Academic › peer-review
-
The Dutch Gastrointestinal Symptom Tracker for People With Cystic Fibrosis: Associations With Anxiety, Depression, and Health-Related Quality of Life
Verkleij, M., Vlieg-Boerstra, B., Hofsteenge, G. H., Haarman, E., Twisk, J., Quittner, A. L. & de Meij, T., 1 Mar 2025, In: Pediatric Pulmonology. 60, 3, e71021.Research output: Contribution to journal › Article › Academic › peer-review
-
Evaluation of Elexacafor/Tezacaftor/Ivacaftor therapy after lung transplantation in Cystic Fibrosis: The Dutch National KOALA study
van Gemert, J. P., Luijk, B., Hellemons, M. E., Visser, K. A., Hansen, C. M. E., van der Meer, R., Gan, C. T., van der Vaart, H., Akkerman, O. W., Steenhuis, W. N. & On behalf of the KOALA study group, 1 Feb 2025, In: JHLT Open. 7, 100210.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
